Benzodrocortisone
Benzodrocortisone, also known as hydrocortisone 17-benzoate, is a synthetic glucocorticoid corticosteroid which was assigned an INN in 2016 and has yet to be marketed.[1]
![]() | |
| Clinical data | |
|---|---|
| Other names | Hydrocortisone 17-benzoate; 11β,17α,21-Trihydroxypregn-4-ene-3,20-dione 17-benzoate; 17α-Benzoyloxypregn-4-ene-11α-ol-3,20-dione |
| Drug class | Corticosteroid; Glucocorticoid |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C28H34O6 |
| Molar mass | 466.574 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
References
- World Health Organization (2016). "Proposed INN: List 116" (PDF). World Health Organization. Retrieved 2017-07-03.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
